OpGen, Inc.’s Strategic Investment With In-Q-Tel Yields Commercial Availability of Optical Mapping Instrument

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc. the leader in microbial genome analysis today announced the placement of the first customer instrument for Optical Mapping. The stand-alone instrument and disposable cartridges are based on OpGen’s proprietary technology which allows for accurate and rapid microbial identification and characterization. The instrument allows for the generation of microbial genome Optical Maps within hours. OpGen is planning to launch the instrument into the lifesciences market in 2009 and expects to submit to the FDA for clinical diagnostic applications in 2010.

MORE ON THIS TOPIC